BioWorld Science

Nov. 24, 1997

View Archived Issues

EntreMed: Q3 1997 highlights

Read More

Olpadronate associated with improvement in osteogenesis imperfecta

Read More

Myriad Genetics and Bayer join forces to develop dementia and depression therapies

Read More

Cantab: Q3 1997 highlights

Read More

Microcide: Q3 1997 highlights

Read More

Clinical trial demonstrates efficacy of NPS-R-568 in hyperparathyroidism

Read More

Affymetrix: Q3 1997 highlights

Read More

Pharmacia & Upjohn: Q3 1997 highlights

Read More

GH secretagogues under development at Merck & Co.

Read More

Mitsui Norin discovers natural antiviral/antitumor agent

Read More

New triazole antifungals from Pfizer

Read More

Lilly claims antithrombotic diamides

Read More

Takeda reports novel carbapenems

Read More

Brain GABA receptor ligands prepared at Neurogen

Read More

DCK analogues with potent and selective anti-HIV activity

Read More

Role of complement in mast cell-dependent natural immunity

Read More

Favorable results obtained in pediatric study of Neuprex

Read More

Phase I trial of multiple-dose IDEC-C2B8 in NHL

Read More

New NK1 antagonist from Novartis

Read More

Six-month trial of lamivudine for chronic hepatitis B

Read More

Role of substance P in PTH secretion described

Read More

FDA advisory committee recommends approval of Rocephin for AOM

Read More

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Read More

NK3 antagonist demonstrates intestinal antiinflammatory activity

Read More

Palatin receives FDA clearance to start LeuTech clinical trials

Read More

Antifungal activity of KP-103 under evaluation

Read More

Gel formulation of diclofenac and hyaluronan effective in aphthous ulcer pain

Read More

Novartis launches once-monthly formulation of Sandostatin

Read More

Combivir recommended for approval in Europe

Read More

Development of new quinolone from Toyama advances

Read More